1. HOME

Business Areas

Business Areas

Celltrion has streamlined our biopharmaceutical process at each stage of the product development pathway.

01 R&D

Celltrion's R&D Capabilities fuel our commitment to developing life-changing pharmaceuticals

The cornerstone of Celltrion’s global biotechnology capabilities is our Global R&D Centre, where we focus on cutting-edge biosimilars and novel drug modalities. Leveraging our wealth of experience in global biosimilar clinical trials, we have secured regulatory approvals in over 100 countries across our portfolio.

  • R&D

    Operates Korea's largest Global R&D Center capable of biologics and small molecules research

  • Clinical Trials

    Successfully accumulated global clinical trial experiences on mAb biopharmaceuticals

  • Regulatory Affairs

    Outstanding capacity dedicated to regulatory approvals and sales of biopharmaceuticals

02 Production

Compliance with Good Manufacturing Practice ensures that we deliver consistently High Quality biopharmaceuticals, We Deliver Consistently High-Quality Biologics Biopharmaceuticals

Celltrion manages the entire biopharmaceutical production process using state-of-the-art manufacturing technologies and rigorous quality control protocols. This commitment to excellence translates into the consistent production of high-quality biopharmaceuticals.

  • 01

    Operates production facilities certified to US, Europe, and UK cGMP standards.

  • 02

    Operates large-scale, in-house manufacturing facilities with a production capacity of 250,000L

  • 03

    World class production capabilities and quality control system

03 Distribution

Our Growing Global Direct Distribution Network Now Reaches Over 100 Countries

Celltrion's biopharmaceuticals reach patients in over 100 countries, including the US and Europe, through our rapidly growing direct distribution network. Our mission is to achieve global access and ensures quality medical care is available at reasonable costs, alleviating financial burdens on public healthcare systems.
Celltrion manages direct distribution through our UK-based office, providing a distinct advantage in supply chain reliability and responsiveness.

  • 01

    Establishment and expansion of direct global sales network

  • 02

    Distributes multiple antibody products in approximately 100 countries

  • 03

    No. 1 manufacturer and exporter of biosimilars in Korea

UK--25-00050 Jan 2026

popup
You are leaving CelltrionHealthcare UK.

The Celltrion Healthcare Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local Celltrion Healthcare affiliate to obtain the appropriate product information for your country of residence.

The Celltrion Healthcare site that you have requested may be in a language that differs from your country of origin. The Celltrion Healthcare site that you have requested may not be optimized for your screen size.

Do you wish to leave this site?